Literature DB >> 16448611

[Consensus document on the use of granulocytapheresis in patients with inflammatory bowel disease].

J L Cabriada1, E Doménech, F Gomollón, P González-Carro, V González-Lara, J Hinojosa, C E Jiménez-López, P Nos, A Obrador, J Panès, C Saro, V Varea, R Lafuente, M Guilera.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16448611     DOI： 10.1157/13083905

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN： 0210-5705            Impact factor:   2.102


× No keyword cloud information.
  3 in total

1.  Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: results of a nationwide Spanish registry.

Authors:  J L Cabriada; E Domènech; N Ibargoyen; V Hernández; J Clofent; D Ginard; I Gutiérrez-Ibarluzea; J Hinojosa
Journal:  J Gastroenterol       Date:  2011-11-23       Impact factor: 7.527

2.  The GRADE approach for assessing new technologies as applied to apheresis devices in ulcerative colitis.

Authors:  Nora Ibargoyen-Roteta; Iñaki Gutiérrez-Ibarluzea; Rosa Rico-Iturrioz; Marta López-Argumedo; Eva Reviriego-Rodrigo; Jose Luis Cabriada-Nuño; Holger J Schünemann
Journal:  Implement Sci       Date:  2010-06-16       Impact factor: 7.327

3.  Post-marketing health technology monitoring. The analysis of an experience from a clinical perspective.

Authors:  Nora Ibargoyen-Roteta; Jose Luis Cabriada-Nuño; Iñaki Gutiérrez-Ibarluzea; Vicent Hernández-Ramírez; Juan Clofent-Vilaplana; Eugeni Domènech-Morral; Daniel Ginard-Vicens; Gloria Oliva-Oliva; Teresa Queiro-Verdes
Journal:  Front Pharmacol       Date:  2011-07-29       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.